Stuart G Turville

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi Resolution of de novo HIV production and trafficking in immature dendritic cells
    Stuart G Turville
    Center for Biomedical Research, Population Council, 1230 York Avenue, New York, New York 10065, USA
    Nat Methods 5:75-85. 2008
  2. ncbi Manipulation of dendritic cell function by viruses
    Anthony L Cunningham
    Centre for Virus Research, Westmead Millennium Institute, University of Sydney, Westmead, NSW 2145, Australia
    Curr Opin Microbiol 13:524-9. 2010
  3. ncbi Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity
    Stuart G Turville
    Center for Biomedical Research, HIV and AIDS Program, Population Council, New York, New York, United States of America
    PLoS ONE 3:e3162. 2008
  4. ncbi Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G
    Susanna Trapp
    HIV and AIDS Program, Center for Biomedical Research, Population Council, New York, New York 10065, USA
    J Virol 83:884-95. 2009
  5. ncbi Diversity of receptors binding HIV on dendritic cell subsets
    Stuart G Turville
    Center for Virus Research, Westmead Millennium Institute, Westmead Hospital and University of Sydney, Sydney, NSW 2145, Australia
    Nat Immunol 3:975-83. 2002
  6. ncbi Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells
    Stuart G Turville
    Centre for Virus Research, Westmead Millennium Institute, Sydney, Australia
    Blood 103:2170-9. 2004
  7. ncbi Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer
    Stuart G Turville
    Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B 3000 Leuven, Belgium
    J Virol 79:13519-27. 2005
  8. ncbi CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics
    Andreas Schweizer
    Division of Infectious Diseases, University Hospital Zurich, Zurich, Switzerland
    PLoS Pathog 4:e1000109. 2008

Collaborators

  • A L Cunningham
  • N Romani
  • Melissa Pope
  • J Balzarini
  • Kurt Vermeire
  • Susanna Trapp
  • Melissa Robbiani
  • Andreas Schweizer
  • Rachel Singer
  • Julian W Bess
  • Nina R Derby
  • Jeffrey D Lifson
  • Andrew Shaw
  • Vennansha G Williams
  • Livia Berlinger
  • Peter Rusert
  • Meropi Aravantinou
  • Patrick Amstutz
  • Claudia R Ruprecht
  • Marek Fischer
  • Axel Mann
  • Stéphanie Corthésy
  • Alexandra Trkola

Detail Information

Publications8

  1. ncbi Resolution of de novo HIV production and trafficking in immature dendritic cells
    Stuart G Turville
    Center for Biomedical Research, Population Council, 1230 York Avenue, New York, New York 10065, USA
    Nat Methods 5:75-85. 2008
    ....
  2. ncbi Manipulation of dendritic cell function by viruses
    Anthony L Cunningham
    Centre for Virus Research, Westmead Millennium Institute, University of Sydney, Westmead, NSW 2145, Australia
    Curr Opin Microbiol 13:524-9. 2010
    ....
  3. ncbi Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity
    Stuart G Turville
    Center for Biomedical Research, HIV and AIDS Program, Population Council, New York, New York, United States of America
    PLoS ONE 3:e3162. 2008
    ..This work also underscores the potential of Carraguard-based formulations for the delivery of anti-viral drugs to prevent vaginal HIV infection...
  4. ncbi Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G
    Susanna Trapp
    HIV and AIDS Program, Center for Biomedical Research, Population Council, New York, New York 10065, USA
    J Virol 83:884-95. 2009
    ..The unique immune stimulation by poly(I:C) with its antiviral effects on imDCs marked by the expression of IFN-alpha/beta and active LMM A3G renders poly(I:C) a promising novel strategy to combat early HIV infection in vivo...
  5. ncbi Diversity of receptors binding HIV on dendritic cell subsets
    Stuart G Turville
    Center for Virus Research, Westmead Millennium Institute, Westmead Hospital and University of Sydney, Sydney, NSW 2145, Australia
    Nat Immunol 3:975-83. 2002
    ..The diversity of CLRs able to bind HIV-1 in skin DCs may reflect their ability to bind a range of microbial glycoproteins...
  6. ncbi Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells
    Stuart G Turville
    Centre for Virus Research, Westmead Millennium Institute, Sydney, Australia
    Blood 103:2170-9. 2004
    ..Thus, the controversy of DCs being infected or not infected for the mechanics of viral transfer to CD4+ lymphocytes can be addressed as a function of time...
  7. ncbi Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer
    Stuart G Turville
    Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B 3000 Leuven, Belgium
    J Virol 79:13519-27. 2005
    ..Thus, our findings indicate that I-SPT may be more elusive to targeting by antiviral drugs and stress the need for drugs affecting the pronounced inhibition of the infection of DCs by HIV-1...
  8. ncbi CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics
    Andreas Schweizer
    Division of Infectious Diseases, University Hospital Zurich, Zurich, Switzerland
    PLoS Pathog 4:e1000109. 2008
    ....